Peng Wang

Peng Wang

Auto-generated profile, based on publicly available information

Peng Wang

Department of Emergency Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; Institute of Cardiopulmonary Cerebral Resuscitation, Sun Yat-sen University, Guangzhou, China

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2011 in Cell Research
Verified
Journal Article
Open access
PDF file
YHYumin Hu
Yumin Hu
WLWeiqin Lu
Weiqin Lu
GCGang Chen
Gang Chen
PWPeng Wang
Peng Wang
ZCZhao Chen
Zhao Chen
PHPeng Huang
Peng Huang
Increased aerobic glycolysis and oxidative stress are important features of cancer cell metabolism, but the underlying biochemical and molecular mechanisms remain elusive. Using a tetracycline inducible model, we show that activation of K-rasG12V causes mitochondrial dysfunction, leading to decreased respiration, elevated glycolysis, and increased generation of reactive oxygen species. The K-RAS protein is associated with mitochondria, and induces a rapid suppression of respiratory chain complex-I and a decrease in mitochondrial transmembrane potential by affecting the cyclosporin-sensitive permeability transition pore. Furthermore, pre-induction of K-rasG12V expression in vitro to allow metabolic adaptation to high glycolytic metabolism enhances the ability of the transformed cells to form tumor in vivo. Our study suggests that induction of mitochondrial dysfunction is an important mechanism by which K-rasG12V causes metabolic changes and ROS stress in cancer cells, and promotes tumor development.

4 October 2013 in Cell Death & Differentiation
Verified
Journal Article
Closed access
PDF file
PLP-P Liu
P-P Liu
JLJ Liao
J Liao
ZTZ-J Tang
Z-J Tang
WWW-J Wu
W-J Wu
JYJ Yang
J Yang
PHP Huang
P Huang

1 November 2015 in Cancer Letters
Verified
Journal Article
Closed access
MMMing-Zhe Ma
Ming-Zhe Ma
GCGang Chen
Gang Chen
PWPeng Wang
Peng Wang
WLWen-Hua Lu
Wen-Hua Lu
CZChao-Feng Zhu
Chao-Feng Zhu
Peng HuangPeng Huang
Peng Huang

12 May 2015 in Oncotarget
Verified
Journal Article
Open access
PDF file
PWPeng Wang
Peng Wang
CZChao-Feng Zhu
Chao-Feng Zhu
MMMing-Zhe Ma
Ming-Zhe Ma
GCGang Chen
Gang Chen
MSMing Song
Ming Song
Peng HuangPeng Huang
Peng Huang
Micro-RNA-155 is induced by K-Ras oncogenic signal and promotes ROS stress in pancreatic cancer

Verified
Journal Article
Open access
PDF file
PWPeng Wang
Peng Wang
JHJian Huang
Jian Huang
YLYi Li
Yi Li
RCRuiming Chang
Ruiming Chang
HWHaidong Wu
Haidong Wu
ZHZitong Huang
Zitong Huang
Carbon monoxide (CO) has shown various physiological effects including anti-inflammatory activity in several diseases, whereas the therapeutic efficacy of CO on sepsis-induced acute kidney injury (AKI) has not been reported as of yet. The purpose of the present study was to explore the effects of exogenous CO on sepsis-induced AKI and nucleotide-binding domain-like receptor protein 3 (NLRP3) inflammasome activation in rats. Male rats were subjected to cecal ligation and puncture (CLP) to induce sepsis and AKI. Exogenous CO delivered from CO-releasing molecule 2 (CORM-2) was used intraperitoneally as intervention after CLP surgery. Therapeutic effects of CORM-2 on sepsis-induced AKI were assessed by measuring serum creatinine (Scr) and blood urea nitrogen (BUN), kidney histology scores, apoptotic cell scores, oxidative stress, levels of cytokines TNF-α and IL-1β, and NLRP3 inflammasome expression. CORM-2 treatment protected against the sepsis-induced AKI as evidenced by reducing serum Scr/BUN levels, apoptotic cells scores, increasing survival rates, and decreasing renal histology scores. Furthermore, treatment with CORM-2 significantly reduced TNF-α and IL-1β levels and oxidative stress. Moreover, CORM-2 treatment significantly decreased NLRP3 inflammasome protein expressions. Our study provided evidence that CORM-2 treatment protected against sepsis-induced AKI and inhibited NLRP3 inflammasome activation, and suggested that CORM-2 could be a potential therapeutic candidate for treating sepsis-induced AKI.

2 April 2013 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
PWPeng Wang
Peng Wang
CMCong Mai
Cong Mai
YWYong-Li Wei
Yong-Li Wei
JZJing-Jing Zhao
Jing-Jing Zhao
YHYu-Min Hu
Yu-Min Hu
Peng HuangPeng Huang
Peng Huang